Merck & Co. Inc.

In News

Merck nears $10 billion deal for London-based lung therapy firm Verona, FT reports - Reuters

Reuters - Jul 09, 2025

Merck nears $10bn deal for respiratory drugmaker Verona - Financial Times

Financial Times - Jul 09, 2025

Merck Nears $10 Billion Deal for Drugmaker Verona, FT Says - Bloomberg

Bloomberg - Jul 09, 2025

Merck eyes $10B buyout of Verona Pharma - report (MRK:NYSE) - Seeking Alpha

Seeking Alpha - Jul 09, 2025

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports - Yahoo Finance

Yahoo Finance - Jul 09, 2025

Merck & Co.: A Pharma Titan At A Discount (NYSE:MRK) - Seeking Alpha

Seeking Alpha - Jul 07, 2025

MERCK: "MY AIM IS TO FORCE CHANGE" - Hits Daily Double

Hits Daily Double - Jul 07, 2025

Merck & Co (MRK) Announces the Approval of ENFLONSIA - Yahoo Finance

Yahoo Finance - Jul 06, 2025

Hipgnosis is back: Merck Mercuriadis launching new company with ‘hundreds of millions’ in investment secured (report) - Music Business Worldwide

Music Business Worldwide - Jul 06, 2025

Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025 - BioSpace

BioSpace - Jul 08, 2025

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports By Reuters - Investing.com

Investing.com - Jul 09, 2025

Merck & Co. close to $10B deal for Verona: report - FirstWord Pharma

FirstWord Pharma - Jul 09, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.